Javascript must be enabled to continue!
Longitudinal stent elongation or shortening after deployment in the coronary arteries: which is dominant?
View through CrossRef
Abstract
Background
Stent manufacturers always record stent shortening data while they do not record stent elongation data. The aim of this study is to identify both stent shortening and elongation occurring after deployment in the coronary arteries and know their percentage.
Results
The length of coronary stents was measured by intravascular ultrasound (IVUS) by (1) edge-to-edge (E-E) length, measured from the appearance of the first distal strut to the last proximal strut, and (2) area-to-area (A-A) length, measured from the first distal struts seen at more than one IVUS quadrant to the last proximal struts seen at more than one IVUS quadrant. Stent shortening was defined as both E-E and A-A lengths were shorter than the manufacturer box-stated length (shortened group). Stent elongation was defined as both E-E and A-A lengths were longer than the manufacturer box-stated length (elongated group), otherwise unchanged group. Consecutive 102 stents deployed in ischemic patients were included. Stent elongation was detected in 67.6% (69 stents), and shortening was detected in 15.7% (16 stents), while unchanged stents were detected in 16.7% (17 stents). Although the 3 groups had similar box-stated length and predicted foreshortened length, they had significantly different measurements by IVUS, p<0.001 for each comparison. Differences from box-stated length were 1.9±1.4mm, −1.4±0.4mm, and 0.4±0.3mm, respectively, p<0.001. The elongated group had significantly longer differences from the corresponding box-stated and predicted foreshortened lengths, while the shortened group had significantly shorter differences from the corresponding box-stated length and similar foreshortened length. By multinomial regression analysis, the plaque-media area and stent deployment pressure were the independent predictors of the stent length groups, p=0.015 and p=0.026, respectively.
Conclusions
Change in stent length is not only shortening—as mentioned in the manufacturer documents—but also stent elongation. Stent elongation is dominant, and the most important predictors of longitudinal stent changes are plaque-media area and stent deployment pressure.
Springer Science and Business Media LLC
Title: Longitudinal stent elongation or shortening after deployment in the coronary arteries: which is dominant?
Description:
Abstract
Background
Stent manufacturers always record stent shortening data while they do not record stent elongation data.
The aim of this study is to identify both stent shortening and elongation occurring after deployment in the coronary arteries and know their percentage.
Results
The length of coronary stents was measured by intravascular ultrasound (IVUS) by (1) edge-to-edge (E-E) length, measured from the appearance of the first distal strut to the last proximal strut, and (2) area-to-area (A-A) length, measured from the first distal struts seen at more than one IVUS quadrant to the last proximal struts seen at more than one IVUS quadrant.
Stent shortening was defined as both E-E and A-A lengths were shorter than the manufacturer box-stated length (shortened group).
Stent elongation was defined as both E-E and A-A lengths were longer than the manufacturer box-stated length (elongated group), otherwise unchanged group.
Consecutive 102 stents deployed in ischemic patients were included.
Stent elongation was detected in 67.
6% (69 stents), and shortening was detected in 15.
7% (16 stents), while unchanged stents were detected in 16.
7% (17 stents).
Although the 3 groups had similar box-stated length and predicted foreshortened length, they had significantly different measurements by IVUS, p<0.
001 for each comparison.
Differences from box-stated length were 1.
9±1.
4mm, −1.
4±0.
4mm, and 0.
4±0.
3mm, respectively, p<0.
001.
The elongated group had significantly longer differences from the corresponding box-stated and predicted foreshortened lengths, while the shortened group had significantly shorter differences from the corresponding box-stated length and similar foreshortened length.
By multinomial regression analysis, the plaque-media area and stent deployment pressure were the independent predictors of the stent length groups, p=0.
015 and p=0.
026, respectively.
Conclusions
Change in stent length is not only shortening—as mentioned in the manufacturer documents—but also stent elongation.
Stent elongation is dominant, and the most important predictors of longitudinal stent changes are plaque-media area and stent deployment pressure.
Related Results
Early Onset of Coronary Subclavian Steal Syndrome: A Case Report and Literature Review
Early Onset of Coronary Subclavian Steal Syndrome: A Case Report and Literature Review
Abstract
Introduction
Coronary subclavian steal syndrome (CSSS) is a rare phenomenon that often goes undiagnosed and causes severe complications, including death. This report prese...
Novel functionalized and patterned surfaces for cardiovascular applications
Novel functionalized and patterned surfaces for cardiovascular applications
Nowadays, cardiovascular diseases are mainly treated by implantation of a metallic or polymeric mesh, called stent, which maintains the artery widely open. This technique shows ver...
e0517 Forearm arteries with ultrasound for percutaneous coronary procedures
e0517 Forearm arteries with ultrasound for percutaneous coronary procedures
Background
The radial artery has become a widely used approach for coronary angiography and intervention in patients, and the ulnar artery is another approach for...
CLINICAL APPLICATION OF DOMESTIC LONG BIODEGRADABLE POLYMER COATED SIROLIMUS ELUTING STENTS FOR TREATMENT OF LONG CORONARY ARTERY LESIONS
CLINICAL APPLICATION OF DOMESTIC LONG BIODEGRADABLE POLYMER COATED SIROLIMUS ELUTING STENTS FOR TREATMENT OF LONG CORONARY ARTERY LESIONS
Objectives
To evaluate the efficacy and safety of domestic long biodegradable polymer coated sirolimus eluting stents (Excel stent, Shandong JW) for treatment of ...
e0543 Clinical and coronary angiography characteristics between young (<45) and old (>60) patients with coronary artery disease
e0543 Clinical and coronary angiography characteristics between young (<45) and old (>60) patients with coronary artery disease
Objective
To study the clinical Clinical and coronary angiography characteristics between young (≤45) and old (>60) patients with coronary artery disease.
...
e0425 Clinical and coronary angiography characteristics between young (≤45) and old (>60) patients with coronary artery disease
e0425 Clinical and coronary angiography characteristics between young (≤45) and old (>60) patients with coronary artery disease
Objective
To study the clinical Clinical and coronary angiography characteristics between young (≤45) and old (>60) patients with coronary artery disease.
...
Fluid and Solid Mechanics in Stented Arteries
Fluid and Solid Mechanics in Stented Arteries
Abstract
Vascular stents are being used in increasing numbers to correct arterial flow limiting disorders. Although data exist on the in vivo performance of these de...
Clinical study of biodegradable polymer stent versus durable polymer stent in treating long coronary lesions
Clinical study of biodegradable polymer stent versus durable polymer stent in treating long coronary lesions
Objective
This study compared the clinical efficacy and safety of homemade biodegradable polymer rapamycin-eluting stent (EXCEL TM) and durable polymer rapamycin-...

